专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2009148291A2 3- OR 4-SUBSTITUTED PIPERIDINE COMPOUNDS 审中-公开
标题翻译： 3-或4-取代的哌啶化合物
公开(公告)号：WO2009148291A2
公开(公告)日：2009-12-10
申请号：PCT/KR2009003042
申请日：2009-06-05
申请人： SK HOLDINGS CO LTD , LEE KI-HO , PARK CHUN-EUNG , MIN KYUNG-HYUN , SHIN YONG-JE , SHIN YU-JIN , YOON HAE-JEONG , KIM WON , RYU EUN-JU
发明人： LEE KI-HO , PARK CHUN-EUNG , MIN KYUNG-HYUN , SHIN YONG-JE , SHIN YU-JIN , YOON HAE-JEONG , KIM WON , RYU EUN-JU
IPC分类号： C07D257/04 , A61K31/445 , C07D257/02
CPC分类号： C07D401/06 , C07D409/14
摘要： There are disclosed racemic or enantiomerically enriched 3- or 4-substituted piperidine compounds represented by the following structural formula (I) or any of their isomers, or pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions containing the subject compounds. The subject compounds are useful for the treatment of diseases of the central nervous system, particularly depression, anxiety and pain disorder.
摘要翻译：公开了由以下结构式（I）表示的外消旋或对映体富集的3-或4-取代的哌啶化合物或其任何异构体或其药学上可接受的盐。还公开了含有本发明化合物的药物组合物。本发明化合物可用于治疗中枢神经系统疾病，特别是抑郁症，焦虑和疼痛障碍。

2. 发明申请

WO2011102684A3 COMPOSITION CONTAINING PLACENTA EXTRACTS 审中-公开
标题翻译：含有特殊提取物的组合物
公开(公告)号：WO2011102684A3
公开(公告)日：2012-01-19
申请号：PCT/KR2011001110
申请日：2011-02-21
申请人： UNIV YEUNGNAM IACF , CHOI IN-HO , LEE DONG-MOK , LEE EUN-JU , LEE KI-HO , CHEON YONG-PIL , CHUN TAE-HOON
发明人： CHOI IN-HO , LEE DONG-MOK , LEE EUN-JU , LEE KI-HO , CHEON YONG-PIL , CHUN TAE-HOON
IPC分类号： A61K35/50 , A61P15/00 , A61P19/10 , C12N5/071
CPC分类号： A61K31/5685 , A61K31/565 , A61K31/568 , A61K35/50 , C12N5/0605
摘要： The present invention relates to a composition containing placenta extracts as active ingredients. More particularly, placenta extracts which are natural substances extracted from placentas of livestock exhibit effects that can replace steroids and reduce adverse effects of steroids, and therefore, can be valuably and widely used as contraceptives, anti-osteoporosis drugs, anti-anemic drugs, therapeutic agents for wasting diseases of muscular atrophy, agents for treating sexual dysfunction, therapeutic agents for wounds, adipocyte differentiation stimulating agents for improving meat quality of livestock, etc.
摘要翻译：本发明涉及含有胎盘提取物作为活性成分的组合物。更具体地说，作为从家畜胎盘中提取的天然物质的胎盘提取物具有能够代替类固醇并减少类固醇的不良反应的作用，因此可以作为避孕药，抗骨质疏松药物，抗贫血药物，治疗剂用于消除肌肉萎缩症的药剂，用于治疗性功能障碍的药剂，用于伤口的治疗剂，用于改善家畜肉质的脂肪细胞分化刺激剂等。

3. 发明申请

WO2008122652A8 CONSTRUCTIONAL UNIT AND FRESH AIR SYSTEM 审中-公开
标题翻译：组件和新风系统
公开(公告)号：WO2008122652A8
公开(公告)日：2009-04-09
申请号：PCT/EP2008054276
申请日：2008-04-09
申请人： MAHLE INT GMBH , MAMMARELLA JOHN RONALD , MARENTETTE JOHN FRANCIS , VANDERVEEN JAMES KENNETH , LEE KI-HO , XIA ZHOUXUAN , BRACKETT STEPHEN EDGAR , ARNOLD PAUL M
发明人： MAMMARELLA JOHN RONALD , MARENTETTE JOHN FRANCIS , VANDERVEEN JAMES KENNETH , LEE KI-HO , XIA ZHOUXUAN , BRACKETT STEPHEN EDGAR , ARNOLD PAUL M
IPC分类号： F02M51/00
CPC分类号： F02M35/10347 , F02F7/006 , F02M35/10039 , F02M35/10078 , F02M35/10104 , F02M35/10111 , F02M35/10216 , F02M35/10249 , F02M35/10288 , F02M35/10321 , F02M35/112 , Y10T137/5987
摘要： The invention relates to a pre-assembled constructional unit (1) of a fresh air system (2) for an internal combustion engine, especially of a motor vehicle. Said constructional unit comprises an electrical unit (3) having respective coils (5) for a plurality of cylinders of the internal combustion engine for actuating a fuel injection valve, said electrical unit having an electric wiring (6) for actuating the coils (5), a plurality of parallel insertion openings (10) that extend coaxially through the coils (5), and a plastic element (9) that is injection-molded on the coils (5) and the wiring (6). The constructional unit further comprises a fuel unit (4) having respective tubular connecting pieces (12) for every coil (5) for receiving a respective injection valve and a distributor housing (13) that contains a fuel distributing compartment (14) on which the parallel connecting pieces (12) are arranged and that has connecting openings (15) which interconnect the distributing compartment (14) to the interior of the connecting pieces (12) so as to communicate therewith, the fuel unit (4) and the electrical unit (3) being mounted to each other in such a manner that the connecting pieces (12) are coaxially inserted in the insertion openings (10).
摘要翻译：本发明涉及一种预组件（1）新鲜的空气调节单元（2）用于内燃发动机，特别是机动车辆，具有电单元（3），每一个都包括用于致动燃料喷射阀的多个所述内燃机（5）的气缸的电线圈，电布线（6），用于致动线圈（5），其具有同轴的多个相互平行的导向的，线圈中的每一个（5）通过插入开口（10）和所述线圈的一个（5）和布线（6 有）注模塑料体（9），（与燃料单元4）5）（对于每个线圈具有用于接收相应的喷射阀，以及具有分配器壳体（13）（燃料分配室14的管状连接件（12））包含所述相互平行的连接件（12）被布置并且具有连接开口（15）通过该分配室（14）与所述连接件（12）的内部通信地连接，其中，所述燃料组件（4）和所述电单元（3）被安装在一起，使得在插入式开口（10）的连接件（12）同轴插入。

4. 发明申请

WO2012141418A3 OPERATING SYSTEM SUPPORTING SCALABLE BANDWIDTH AND FEMTOCELL BASE STATION 审中-公开
标题翻译：运行系统支持可扩展的带宽和FEMTOCELL基站
公开(公告)号：WO2012141418A3
公开(公告)日：2012-12-13
申请号：PCT/KR2012000760
申请日：2012-01-31
申请人： KT CORP , LEE KI-HO , LEE YONG-GYOO , JI YUNG-HA
发明人： LEE KI-HO , LEE YONG-GYOO , JI YUNG-HA
IPC分类号： H04W28/20 , H04W88/08
CPC分类号： H04W28/048 , H04W16/32 , H04W28/04 , H04W28/06 , H04W28/20 , H04W84/045
摘要： Femtocell base stations, which are installed in a premises positioned within a macrocell coverage, having a separate femtocell coverage, measures the size of a macrocell interference signal, which is received from a neighboring macrocell base station, and transmits same to an operating system. Then the operating system sets a scalable bandwidth for each of the femtocell base stations, according to the size of each of the macrocell interference signals, by periodically receiving the size of the each of the macrocell interference signals, which are measured by each of the femtocell base station.
摘要翻译：安装在位于宏小区覆盖范围内的场所中的毫微微小区基站具有单独的毫微微小区覆盖，测量从相邻宏小区基站接收的宏小区干扰信号的大小，并将其发送到操作系统。然后，操作系统通过周期性地接收由每个毫微微蜂窝基站测量的每个宏小区干扰信号的大小，根据每个宏小区干扰信号的大小，为每个毫微微小区基站设置可扩展带宽基站。

5. 发明申请

WO2012141423A3 SYSTEM AND METHOD FOR MEASURING MACROCELL QUALITY BY USING FEMTOCELL 审中-公开
标题翻译：使用FEMTOCELL测量宏块质量的系统和方法
公开(公告)号：WO2012141423A3
公开(公告)日：2012-12-13
申请号：PCT/KR2012001058
申请日：2012-02-13
申请人： KT CORP , LEE KI-HO , LEE YONG-GYOO , JI YUNG-HA
发明人： LEE KI-HO , LEE YONG-GYOO , JI YUNG-HA
IPC分类号： H04W24/10 , H04W16/32 , H04W24/04
CPC分类号： H04W24/10 , H04W84/045
摘要： A system for measuring quality comprises a femtocell gateway, femtocell base stations, and a quality measurement server, wherein the quality measurement server generates and transmits to the femtocell gateway an event information including a critical value for each item, a macrocell identification information, and report cycle information, when the femtocell gateway operates together with the femtocell base stations and the quality measurement server, so that the system for measuring quality can measure the quality of a macrocell including the femtocell base stations. When the femtocell gateway transmits to the femtocell base stations the event information on the basis of the macrocell identification information, the femtocell base stations set a critical value range and a report cycle on the basis of an event identification information. When the femtocell base stations collect a macrocell quality information, whether the collected macrocell quality information exceeds a predetermined critical value range is determined, and the macrocell quality information, which is collected based on a set report cycle, is transmitted to the quality measurement server through the femtocell gateway when the collected macrocell quality information exceeds the critical value range.
摘要翻译：用于测量质量的系统包括毫微微小区网关，毫微微小区基站和质量测量服务器，其中质量测量服务器生成并向毫微微小区网关发送包括每个项目的临界值的事件信息，宏小区标识信息和报告当毫微微小区网关与毫微微小区基站和质量测量服务器一起运行时，使得用于测量质量的系统可以测量包括毫微微小区基站的宏小区的质量。当毫微微小区网关基于宏小区识别信息向毫微微小区基站发送事件信息时，毫微微小区基站基于事件识别信息设置临界值范围和报告周期。当毫微微小区基站收集宏小区质量信息时，确定所收集的宏小区质量信息是否超过预定临界值范围，并且基于设定的报告周期收集的宏小区质量信息被传送到质量测量服务器，通过当所收集的宏单元质量信息超过临界值范围时，毫微微小区网关。

6. 发明申请

WO2012141424A3 METHOD AND APPARATUS FOR CONTROLLING FEMTOCELL CONNECTION 审中-公开
标题翻译：用于控制FEMTOCELL连接的方法和装置
公开(公告)号：WO2012141424A3
公开(公告)日：2013-01-10
申请号：PCT/KR2012001087
申请日：2012-02-14
申请人： KT CORP , LEE KI-HO , LEE YONG-GYOO , JI YUNG-HA
发明人： LEE KI-HO , LEE YONG-GYOO , JI YUNG-HA
IPC分类号： H04W36/04 , H04W36/30 , H04W36/38 , H04W48/02
CPC分类号： H04W36/0061 , H04W36/0083 , H04W48/02 , H04W84/045
摘要： A second femtocell base station generates a handover permission message with regard to a plurality of neighboring femtocell base stations when the second femtocell base station has a closed subscriber group (CSG) identifier that is different from a CSG identifier of a first femtocell base station, so that a user equipment can control a handover, wherein the second femtocell base station neighbors a first femtocell base station that is connected to the user equipment. The handover permission message that is generated is transmitted to and saved in a gateway, which is connected to the second femtocell base station, and a handover between femtocells is controlled by selecting a resource to be provided to the terminal and connecting to the user equipment, when the handover with regard to the terminal is requested from the gateway.
摘要翻译：当第二毫微微小区基站具有与第一毫微微小区基站的CSG标识符不同的封闭用户组（CSG）标识符时，第二毫微微小区基站关于多个相邻毫微微小区基站生成切换许可消息，因此用户设备可以控制切换，其中第二毫微微小区基站邻近与用户设备连接的第一毫微微小区基站。生成的切换允许消息被发送到并保存在连接到第二毫微微小区基站的网关中，并且通过选择要提供给终端并连接到用户设备的资源来控制毫微微小区之间的切换，当从网关请求关于终端的切换时。

7. 发明申请

WO2012053768A3 ARYLOXYPHENOXYACETYL-BASED COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT 审中-公开
标题翻译：具有HIF-1抑制活性的含有芳基氧基乙酰基的化合物，其制备方法和含有其作为活性成分的药物组合物
公开(公告)号：WO2012053768A3
公开(公告)日：2012-06-21
申请号：PCT/KR2011007589
申请日：2011-10-12
申请人： KOREA RES INST OF BIOSCIENCE , UNIV DONGGUK IND ACAD COOP , WON MI-SUN , KIM HWAN-MOOK , LEE KYEONG , PARK SONG-KYU , LEE KI-HO , LEE CHANG-WOO , LEE JUNG-JOON , CHUNG KYUNG-SOOK , KIM BO-KYUNG , JIN YING-LAN
发明人： WON MI-SUN , KIM HWAN-MOOK , LEE KYEONG , PARK SONG-KYU , LEE KI-HO , LEE CHANG-WOO , LEE JUNG-JOON , CHUNG KYUNG-SOOK , KIM BO-KYUNG , JIN YING-LAN
IPC分类号： C07C235/38 , A61K31/167 , A61P35/00 , C07C231/02
CPC分类号： C07C235/24 , C07C2603/74
摘要： Disclosed are a compound inhibitory of HIF-1 activity, a method for preparing the same, and a pharmaceutical composition comprising the same as an active ingredient. The compound has anticancer activity which is attributable to its inhibitory activity against HIF-1, but not to non-selective cellular toxicity. Thus, having inhibitory activity against HIF-1, the compound or a pharmaceutically acceptable salt thereof can be used as an ingredient in an anticancer agent for various cancers including large intestine cancer, hepatic cancer, stomach cancer and breast cancer. Further, the compound or a pharmaceutically acceptable salt thereof is applicable to the treatment of diabetic retinopathy or arthritis which is aggravated upon the activation of VEGFA by HIF-1.
摘要翻译：公开了HIF-1活性的化合物抑制剂，其制备方法，以及含有该化合物作为活性成分的药物组合物。该化合物具有抗癌活性，其归因于其对HIF-1的抑制活性，但不归因于非选择性细胞毒性。因此，对于HIF-1具有抑制活性，该化合物或其药学上可接受的盐可用作各种癌症，包括大肠癌，肝癌，胃癌和乳腺癌的抗癌剂中的成分。此外，化合物或其药学上可接受的盐适用于治疗通过HIF-1激活VEGFA时加重的糖尿病性视网膜病变或关节炎。

8. 发明申请

WO2010126249A2 FEMTOCELL ACCESS POINT FOR AUTOMATICALLY SETTING AND REGISTERING LOCATION-RELATED UNIQUE IDENTIFICATION INFORMATION, AND METHOD FOR SAME 审中-公开
标题翻译：用于自动设置和注册与位置相关的唯一标识信息的FEMTOCELL接入点及其相关方法
公开(公告)号：WO2010126249A2
公开(公告)日：2010-11-04
申请号：PCT/KR2010002509
申请日：2010-04-21
申请人： KT CORP , LEE KI-HO , LEE HEE-JUN , PARK JOONG-WAN , PARK JONG-HO
发明人： LEE KI-HO , LEE HEE-JUN , PARK JOONG-WAN , PARK JONG-HO
IPC分类号： H04W16/18 , H04B7/26
CPC分类号： H04W24/02 , H04W8/26 , H04W28/06 , H04W48/16 , H04W84/045
摘要： The present invention relates to a femtocell access point to be located in the coverage of a macrocell to automatically set and register location-related unique identification information thereof, considering location-related unique identification information of the macrocell. The present invention also relates to a method for same. The femtocell access point to be located in the coverage of a macrocell according to the present invention comprises: a receiving unit which receives a broadcast signal from the macrocell; an extraction unit which extracts location-related unique identification information of the macrocell from the received broadcast signal; and a setting unit which sets the extracted location-related unique identification information as location-related unique identification information of a femtocell. The femtocell access point sets location-related unique identification information identical to that of the macrocell, and transmits a broadcast signal to a mobile terminal, to thereby prevent frequent location registration of the mobile terminal and enabling the mobile terminal to receive the same paging message in the macrocell and the femtocell.
摘要翻译：本发明涉及考虑宏小区的位置相关的唯一识别信息，位于宏小区的覆盖范围内的毫微微小区接入点，以自动设置和注册位置相关的唯一识别信息。本发明还涉及其相应的方法。根据本发明的位于宏小区的覆盖范围内的毫微微小区接入点包括：接收单元，其从宏小区接收广播信号; 提取单元，从接收到的广播信号中提取宏小区的位置相关唯一识别信息; 以及设置单元，其将所提取的位置相关的唯一标识信息设置为毫微微小区的位置相关唯一标识信息。毫微微小区接入点设置与宏小区的位置相关的唯一识别信息，并将广播信号发送到移动终端，从而防止移动终端的频繁位置登记，并使移动终端能够接收相同的寻呼消息宏小区和毫微微小区。

9. 发明申请

WO2010123243A2 COMPOSITION CONTAINING A TESTIS EXTRACT FOR TREATING OR PREVENTING DISEASES 审中-公开
标题翻译：包含用于治疗或预防疾病的检测提取物的组合物
公开(公告)号：WO2010123243A2
公开(公告)日：2010-10-28
申请号：PCT/KR2010002438
申请日：2010-04-20
申请人： UNIV YEUNGNAM IACF , CHOI IN-HO , LEE DONG-MOK , LEE EUN-JU , LEE KI-HO , CHEON YONG-PIL , CHUN TAE-HOON
发明人： CHOI IN-HO , LEE DONG-MOK , LEE EUN-JU , LEE KI-HO , CHEON YONG-PIL , CHUN TAE-HOON
IPC分类号： A61K35/48 , A61P15/00 , A61P19/00 , A61P21/00 , A61P37/00
CPC分类号： A61K35/48
摘要： The present invention relates to a composition containing a testis extract for treating or preventing diseases. More particularly, a testis extract, which is a natural substance obtained by separating sex hormones containing anabolic steroids from the testes of livestock, is used as contraceptives, drugs for treating osteoporosis, an antianemic agent, a therapeutic agent for wasting diseases of muscular atrophy, an agent for treating sexual dysfunction, a therapeutic agent for immune diseases, a therapeutic agent for wounds, etc., thereby replacing conventional steroids, reducing the side effects of steroids and treating a wide range of human diseases.
摘要翻译：本发明涉及含有用于治疗或预防疾病的睾丸提取物的组合物。更具体地说，作为通过从家畜睾丸中分离含有合成代谢类固醇的性激素获得的天然物质的睾丸提取物被用作避孕药，用于治疗骨质疏松症的药物，抗增援剂，用于消除肌肉萎缩疾病的治疗剂，用于治疗性功能障碍的药物，免疫疾病的治疗剂，伤口的治疗剂等，从而代替常规类固醇，减少类固醇的副作用并治疗广泛的人类疾病。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式